Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Hepatitis B Vaccine in Adults ≥50 Years
NCT04540653Phase 4Unknown
- Sponsor
- Universidade Federal de Goiás
- Start
- Jul 2017
- Primary completion
- Jul 2020
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Universidade Federal de Goiás. Status: unknown.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04540653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04540653.